These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 3220965)

  • 1. Symposium on Tardive Dyskinesia. November 6 and 7, 1987, Montreal, Quebec, Canada. Proceedings.
    J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):1S-76S. PubMed ID: 3220965
    [No Abstract]   [Full Text] [Related]  

  • 2. Animal models of tardive dyskinesia--a review.
    Kulkarni SK; Naidu PS
    Indian J Physiol Pharmacol; 2001 Apr; 45(2):148-60. PubMed ID: 11480221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Colloquium. Tardive dyskinesia: evaluation of current knowledge. Casablanca (Morocco), October 15-16 1987. Proceedings].
    Encephale; 1988 Sep; 14 Spec No():153-269. PubMed ID: 3215141
    [No Abstract]   [Full Text] [Related]  

  • 4. Animal models of tardive dyskinesia [proceedings].
    Davidson AB
    Psychopharmacol Bull; 1981 Jan; 17(1):45-7. PubMed ID: 7232657
    [No Abstract]   [Full Text] [Related]  

  • 5. Tardive dyskinesia: pathophysiology and animal models.
    Casey DE
    J Clin Psychiatry; 2000; 61 Suppl 4():5-9. PubMed ID: 10739324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders.
    Ganzini L; Casey DE; Hoffman WF; McCall AL
    Arch Intern Med; 1993 Jun; 153(12):1469-75. PubMed ID: 8512437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuroleptic medication and the risk of tardive dyskinesia: a survey of psychiatrists and general practitioners in Quebec].
    Cohen D; Bisson J
    Sante Ment Que; 1997; 22(1):263-82. PubMed ID: 9233282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tardive dyskinesia and impaired glucose tolerance.
    Chong SA; Mythily ; Lum A; Huak CY; Kane J
    Hum Psychopharmacol; 2002 Aug; 17(6):305-7. PubMed ID: 12404676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does clozapine cause tardive dyskinesia?
    Kane JM; Woerner MG; Pollack S; Safferman AZ; Lieberman JA
    J Clin Psychiatry; 1993 Sep; 54(9):327-30. PubMed ID: 8104929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of a drug holiday on relapse and tardive dyskinesia in chronic schizophrenics [proceedings].
    Goldberg SC; Shenoy RS; Sadler A; Hamer R; Ross B
    Psychopharmacol Bull; 1981 Jan; 17(1):116-7. PubMed ID: 7232638
    [No Abstract]   [Full Text] [Related]  

  • 11. Dopaminergic and GABAergic aspects of tardive dyskinesia [proceedings].
    Casey DE; Gerlach J; Magelund G; Christensen TR
    Psychopharmacol Bull; 1981 Jan; 17(1):49-50. PubMed ID: 7232658
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical effectiveness of the Kampo medicine kamishoyosan for adjunctive treatment of tardive dyskinesia in patients with schizophrenia: a 16-week open trial.
    Lee JG; Shin BS; Lee YC; Park SW; Kim YH
    Psychiatry Clin Neurosci; 2007 Oct; 61(5):509-14. PubMed ID: 17875029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clozapine in tardive dyskinesia: observations from human and animal model studies.
    Tamminga CA; Thaker GK; Moran M; Kakigi T; Gao XM
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():102-6. PubMed ID: 7961550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tardive dyskinesia and glucid metabolism.
    Brousse G; Meary A; Mouret J; Blanc O; Hueber T; Lemoine P; Llorca PM; Lachaux B
    Hum Psychopharmacol; 2007 Aug; 22(6):373-80. PubMed ID: 17579925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventing tardive dyskinesia and preventing tardive dyskinesia litigation.
    Gualtieri CT; Sprague RL
    Psychopharmacol Bull; 1984; 20(3):346-8. PubMed ID: 6473628
    [No Abstract]   [Full Text] [Related]  

  • 16. Distinguishing akathisia and tardive dyskinesia: a review of the literature.
    Munetz MR; Cornes CL
    J Clin Psychopharmacol; 1983 Dec; 3(6):343-50. PubMed ID: 6139392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study.
    Bai YM; Yu SC; Lin CC
    J Clin Psychiatry; 2003 Nov; 64(11):1342-8. PubMed ID: 14658949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzyme studies in tardive dyskinesia. I. One-year biochemical follow-up.
    Wagner RL; Jeste DV; Phelps BH; Wyatt RD
    J Clin Psychopharmacol; 1982 Oct; 2(5):312-4. PubMed ID: 7130432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dose reduction of conventional antipsychotics: does it reduce tardive dyskinesia?].
    van Berkel M; Bogers JP; Bouvy PF
    Tijdschr Psychiatr; 2007; 49(1):37-41. PubMed ID: 17225204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary findings with regard to risk factors in the development of tardive dyskinesia [proceedings].
    Kane J; Struve F; Woerner M; Weinhold P
    Psychopharmacol Bull; 1981 Jan; 17(1):47-9. PubMed ID: 6112775
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.